280 related articles for article (PubMed ID: 7911785)
41. Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18.
Harms RZ; Creer AJ; Lorenzo-Arteaga KM; Ostlund KR; Sarvetnick NE
Front Immunol; 2017; 8():1020. PubMed ID: 28900426
[TBL] [Abstract][Full Text] [Related]
42. Endogeneous interferon alpha/beta produced by murine Kupffer cells augments liver-associated natural killing activity.
Werner-Wasik M; von Muenchhausen W; Nolan JP; Cohen SA
Cancer Immunol Immunother; 1989; 28(2):107-15. PubMed ID: 2917363
[TBL] [Abstract][Full Text] [Related]
43. The role of IFN-γ-mediated host immune responses in monitoring and the elimination of Toxoplasma gondii infection.
Ihara F; Yamamoto M
Int Immunol; 2024 Apr; 36(5):199-210. PubMed ID: 38175650
[TBL] [Abstract][Full Text] [Related]
44. Induction of an endogenous tumor necrosis factor in mice by murine recombinant interferon-gamma combined with a lipid A subunit analog (GLA-60) of low toxicity.
Saiki I; Maeda H; Sakurai T; Murata J; Iida J; Kiso M; Hasegawa A; Azuma I
Cancer Immunol Immunother; 1989; 29(2):101-8. PubMed ID: 2497979
[TBL] [Abstract][Full Text] [Related]
45. Functional integration of natural killer cells in a microfluidically perfused liver on-a-chip model.
Fahrner R; Gröger M; Settmacher U; Mosig AS
BMC Res Notes; 2023 Oct; 16(1):285. PubMed ID: 37865791
[TBL] [Abstract][Full Text] [Related]
46. Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng.
Sun X; Nagahama Y; Singh SK; Kozakai Y; Nabeshima H; Fukushima K; Tanaka H; Motooka D; Fukui E; Vivier E; Diez D; Akira S
Immunity; 2024 Jun; 57(6):1360-1377.e13. PubMed ID: 38821052
[TBL] [Abstract][Full Text] [Related]
47. Cutting Edge: STAT4 Promotes Bhlhe40 Induction to Drive Protective IFN-γ from NK Cells during Viral Infection.
Kim H; Abbasi A; Sharrock J; Santosa EK; Sheppard S; Lau CM; Edelson BT; Sun JC
J Immunol; 2023 Nov; 211(10):1469-1474. PubMed ID: 37830760
[TBL] [Abstract][Full Text] [Related]
48. In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor.
Voth R; Rossol S; Gallati H; Pracht I; Laubenstein HP; Hess G; Müller WE; Schröder HC; Jochum C; Meyer zum Büschenfelde KH
Cancer Immunol Immunother; 1988; 27(2):128-32. PubMed ID: 2458181
[TBL] [Abstract][Full Text] [Related]
49. Enhanced natural killer activity and production of pro-inflammatory cytokines in mice selected for high acute inflammatory response (AIRmax).
Castoldi L; Golim MA; Filho OG; Romagnoli GG; Ibañez OC; Kaneno R
Immunology; 2007 Mar; 120(3):372-9. PubMed ID: 17163963
[TBL] [Abstract][Full Text] [Related]
50. The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents.
Pantic JM; Jovanovic IP; Radosavljevic GD; Arsenijevic NN; Conlon JM; Lukic ML
Molecules; 2017 Dec; 22(12):. PubMed ID: 29236056
[TBL] [Abstract][Full Text] [Related]
51. IFN-γ stimulated murine and human neurons mount anti-parasitic defenses against the intracellular parasite Toxoplasma gondii.
Chandrasekaran S; Kochanowsky JA; Merritt EF; Lagas JS; Swannigan A; Koshy AA
Nat Commun; 2022 Aug; 13(1):4605. PubMed ID: 35941154
[TBL] [Abstract][Full Text] [Related]
52. Cell-Specific Requirements for STAT Proteins and Type I IFN Receptor Signaling Discretely Regulate IL-24 and IL-10 Expression in NK Cells and Macrophages.
Dabitao D; Hedrich CM; Wang F; Vacharathit V; Bream JH
J Immunol; 2018 Mar; 200(6):2154-2164. PubMed ID: 29436412
[No Abstract] [Full Text] [Related]
53. Robust anti-tumor immunity and memory in Rag-1-deficient mice following adoptive transfer of cytokine-primed splenocytes and tumor CD80 expression.
Ganesan PL; Alexander SI; Watson D; Logan GJ; Zhang GY; Alexander IE
Cancer Immunol Immunother; 2007 Dec; 56(12):1955-65. PubMed ID: 17549473
[TBL] [Abstract][Full Text] [Related]
54. Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity.
Economou JS; Hoban M; Lee JD; Essner R; Swisher S; McBride W; Hoon DB; Morton DL
Cancer Immunol Immunother; 1991; 34(1):49-52. PubMed ID: 1760811
[TBL] [Abstract][Full Text] [Related]
55. Augmented IFN-γ and TNF-α Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10.
Bui VT; Tseng HC; Kozlowska A; Maung PO; Kaur K; Topchyan P; Jewett A
Front Immunol; 2015; 6():576. PubMed ID: 26697005
[TBL] [Abstract][Full Text] [Related]
56. Synergistic effect of interleukin-15 and interleukin-12 on antitumor activity in a murine malignant pleurisy model.
Kimura K; Nishimura H; Matsuzaki T; Yokokura T; Nimura Y; Yoshikai Y
Cancer Immunol Immunother; 2000 May; 49(2):71-7. PubMed ID: 10823416
[TBL] [Abstract][Full Text] [Related]
57. IFNL cytokines do not modulate human or murine NK cell functions.
Morrison MH; Keane C; Quinn LM; Kelly A; O'Farrelly C; Bergin C; Gardiner CM
Hum Immunol; 2014 Sep; 75(9):996-1000. PubMed ID: 24994459
[TBL] [Abstract][Full Text] [Related]
58. Aberrant anti-viral response of natural killer cells in severe asthma.
Devulder J; Chenivesse C; Ledroit V; Fry S; Lobert PE; Hober D; Tsicopoulos A; Duez C
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32108047
[TBL] [Abstract][Full Text] [Related]
59. High-free Fatty Acid Treatment Induced Anti-inflammatory Changes in a Natural Killer (NK) Cell Line.
Wu H; Fu Y; Jiang Y; Liu Y; Cheng Z; Shao Y; Nie Y
Iran J Immunol; 2023 Dec; 20(4):456-465. PubMed ID: 37865874
[TBL] [Abstract][Full Text] [Related]
60. Immune enhancement and anti-tumour activity of IL-23.
Hao JS; Shan BE
Cancer Immunol Immunother; 2006 Nov; 55(11):1426-31. PubMed ID: 16676182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
